Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does OMACETAXINE MEPESUCCINATE Cause Pyrexia? 56 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 56 reports of Pyrexia have been filed in association with OMACETAXINE MEPESUCCINATE. This represents 5.9% of all adverse event reports for OMACETAXINE MEPESUCCINATE.

56
Reports of Pyrexia with OMACETAXINE MEPESUCCINATE
5.9%
of all OMACETAXINE MEPESUCCINATE reports
4
Deaths
36
Hospitalizations

How Dangerous Is Pyrexia From OMACETAXINE MEPESUCCINATE?

Of the 56 reports, 4 (7.1%) resulted in death, 36 (64.3%) required hospitalization, and 1 (1.8%) were considered life-threatening.

Is Pyrexia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for OMACETAXINE MEPESUCCINATE. However, 56 reports have been filed with the FAERS database.

What Other Side Effects Does OMACETAXINE MEPESUCCINATE Cause?

Myelosuppression (178) Nausea (154) Platelet count decreased (105) Fatigue (76) Diarrhoea (73) White blood cell count decreased (71) Vomiting (63) Injection site erythema (61) Death (60) Asthenia (57)

What Other Drugs Cause Pyrexia?

ADALIMUMAB (12,160) METHOTREXATE (10,158) RITUXIMAB (10,061) PREDNISONE (8,141) ETANERCEPT (7,626) INFLIXIMAB (6,560) ACETAMINOPHEN (6,414) CYCLOPHOSPHAMIDE (6,126) TOCILIZUMAB (5,529) LENALIDOMIDE (5,496)

Which OMACETAXINE MEPESUCCINATE Alternatives Have Lower Pyrexia Risk?

OMACETAXINE MEPESUCCINATE vs OMADACYCLINE OMACETAXINE MEPESUCCINATE vs OMALIZUMAB OMACETAXINE MEPESUCCINATE vs OMAVELOXOLONE OMACETAXINE MEPESUCCINATE vs OMBITASVIR OMACETAXINE MEPESUCCINATE vs OMBITASVIR\PARITAPREVIR\RITONAVIR

Related Pages

OMACETAXINE MEPESUCCINATE Full Profile All Pyrexia Reports All Drugs Causing Pyrexia OMACETAXINE MEPESUCCINATE Demographics